United States · FDA National Drug Code directory
Guanfacine Extended-Release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24979-538_6634768f-1e5a-4604-9587-fe5ffbd7e331
- Product NDC
- 24979-538
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Guanfacine
- Labeler
- Upsher-Smith Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170707
- Source listing expiry
- 20261231
Source-listed ingredients
- GUANFACINE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100000 TABLET, EXTENDED RELEASE in 1 DRUM (24979-538-00) · 24979-538-00
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-538-01) · 24979-538-01
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-538-10) · 24979-538-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →